Neuland Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 300.61 | 335.82 | 457.72 |
| Operating Expense | 258.46 | 277.61 | 311.66 |
| Net Profit | 13.71 | 27.73 | 101.39 |
| Net Profit Margin | 4.56 | 8.26 | 22.15 |
| Earning Per Share | 10.68 | 21.62 | 79.03 |
| EBIDTA | 42.85 | 52.91 | 144.83 |
| Effective Tax Rate | 10.37 | 10.20 | 17.06 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 300.61 |
| Operating Expense | 258.46 |
| Net Profit | 13.71 |
| Net Profit Margin | 4.56 |
| Earning Per Share | 10.68 |
| EBIDTA | 42.85 |
| Effective Tax Rate | 10.37 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,476.84 | 1,558.58 | 1,191.20 |
| Operating Expenses Annual | 1,154.54 | 1,096.66 | 919.89 |
| Operating Profit Annual | 419.21 | 474.47 | 281.06 |
| Interest Annual | 8.30 | 14.00 | 13.07 |
| Depreciation | 64.22 | 58.64 | 51.52 |
| Net Profit Annual | 259.43 | 299.60 | 163.12 |
| Tax Annual | 85.95 | 101.17 | 52.09 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,476.84 |
| Operating Expenses Annual | 1,154.54 |
| Operating Profit Annual | 419.21 |
| Interest Annual | 8.30 |
| Depreciation | 64.22 |
| Net Profit Annual | 259.43 |
| Tax Annual | 85.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 86.07 | 44.96 | 3.72 |
| Cash Flow from Operations | 317.49 | 260.06 | 238.53 |
| Cash Flow from Investing | -298.14 | -149.67 | -61.50 |
| Cash Flow from Financing | 24.96 | -69.28 | -135.80 |
| Cash Flow at the End | 130.38 | 86.07 | 44.96 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 86.07 |
| Cash Flow from Operations | 317.49 |
| Cash Flow from Investing | -298.14 |
| Cash Flow from Financing | 24.96 |
| Cash Flow at the End | 130.38 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 23.71 | 30.44 | 23.59 |
| PBIT Margin (%) | 19.27 | 26.61 | 19.16 |
| PBT Margin (%) | 16.95 | 24.71 | 17.69 |
| Net PROFIT Margin (%) | 17.57 | 19.22 | 13.69 |
| Return On Networth / Equity (%) | 14.86 | 26.48 | 17.90 |
| Return On Networth /Employed (%) | 18.61 | 33.13 | 20.64 |
| Return On Assets (%) | 17.04 | 23.84 | 14.79 |
| Total Debt / Equity (X) | 0.09 | 0.10 | 0.20 |
| Asset Turnover Ratio (%) | 0.97 | 1.24 | 1.08 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 23.71 |
| PBIT Margin (%) | 19.27 |
| PBT Margin (%) | 16.95 |
| Net PROFIT Margin (%) | 17.57 |
| Return On Networth / Equity (%) | 14.86 |
| Return On Networth /Employed (%) | 18.61 |
| Return On Assets (%) | 17.04 |
| Total Debt / Equity (X) | 0.09 |
| Asset Turnover Ratio (%) | 0.97 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 958.00 | 804.63 | 738.19 |
| Total Current Assets Annual | 1,137.82 | 919.47 | 760.34 |
| Non Current Assets Annual | 1,040.35 | 911.46 | 819.00 |
| Total Shareholders Funds Annual | 1,517.79 | 1,276.54 | 988.36 |
| Total Assets Annual | 2,178.17 | 1,830.93 | 1,579.34 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 958.00 |
| Total Current Assets Annual | 1,137.82 |
| Non Current Assets Annual | 1,040.35 |
| Total Shareholders Funds Annual | 1,517.79 |
| Total Assets Annual | 2,178.17 |
EPS (INR)
Expected
10.78
Reported
10.83
Surprise
0.46%
Mar 2025
EPS beaten by 0.46%
Dec 2024
EPS beaten by 0.51%
Sep 2024
EPS beaten by 0.55%
